A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Mikhail Binnewies et al.|Nature Medicine|2018Cited by 1k
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell ImmunityMikhail Binnewies, Matthew F. Krummel, Adriana M. Mujal et al.|Cell|2019Cited by 617